Novavax (NVAX) Cash & Equivalents (QoQ) (2010 - 2026)
Powered by 
Analysis
Novavax (NVAX) Cash & Equivalents (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Novavax | 1.67 Bn | 948.56 Mn | 42.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.16% |
| Mar 31, 2026 | -5.08% |
| Dec 31, 2025 | -10.22% |
| Sep 30, 2025 | 5.63% |
| Jun 30, 2025 | -3.64% |
| Mar 31, 2025 | -50.34% |
| Dec 31, 2024 | -7.57% |
| Sep 30, 2024 | -15.67% |
| Jun 30, 2024 | 41.53% |
| Mar 31, 2024 | -15.46% |
| Dec 31, 2023 | -12.69% |
| Sep 30, 2023 | 28.70% |
| Jun 30, 2023 | -19.05% |
| Mar 31, 2023 | -53.25% |
| Dec 31, 2022 | 4.40% |
| Sep 30, 2022 | -6.91% |
| Jun 30, 2022 | -12.44% |
| Mar 31, 2022 | 3.69% |
| Dec 31, 2021 | -21.78% |
| Sep 30, 2021 | -6.65% |